Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 4/20 | 0.48 |
| ▸ | MAOB | P27338 | 4/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10494843 | 0.87 | ALDH1A1 (0.56) | ALDH1A1MAPK1MAOAMAOBCYP2C19 | |
| SCHEMBL11617330 | 0.78 | MAOA (0.49) | ALDH1A1MAOAMAOBCYP2C19CYP1A2 | |
| SCHEMBL7835696 | 0.78 | CYP19A1 (0.41) | ALDH1A1MAPK1MAOAMAOB | |
| SCHEMBL15856977 | 0.78 | NPC1 (0.47) | ALDH1A1MAPK1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL9451913 | 0.77 | ALDH1A1 (0.61) | ALDH1A1MAPK1MAOAMAOBCYP2C19 | |
| SCHEMBL776647 | 0.77 | ALDH1A1 (1.00) | ALDH1A1MAPK1MAOAMAOBCYP2C19 | |
| SCHEMBL4654471 | 0.77 | MAOA (0.37) | ALDH1A1MAPK1MAOAMAOBHTT | |
| SCHEMBL11852467 | 0.77 | LMNA (0.39) | ALDH1A1MAPK1MAOAMAOBSMN1; SMN2 | |
| SCHEMBL8168991 | 0.77 | MAOA (0.47) | ALDH1A1MAPK1MAOAMAOBHTT | |
| SCHEMBL1931888 | 0.76 | ALDH1A1 (0.52) | ALDH1A1MAPK1MAOAMAOBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190216726-A1 | Particles, Compositions and Methods for Ophthalmic and/or Other Applications | OXFORD FINANCE LLC | 2019-07-18 | — | — | US | disclosed |
| WO-2018053321-A1 | PARTICLES, COMPOSITIONS, AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | KALA PHARMACEUTICALS, INC. (US) | 2018-03-22 | — | — | WO | disclosed |
| US-20050006246-A1 | Nitrogen atom transfer | YUDIN ANDREI K (CA) | 2005-01-13 | — | — | US | disclosed |
| WO-2003010361-A2 | NITROGEN ATOM TRANSFER | YLEKTRA INC. (CA) | 2003-02-06 | — | — | WO | disclosed |
| US-4536599-A | HYDROLYZING THE NITRILE DERIVATIVE TO THE AMIDE USING AN ORGANIC QUATERNARY AMINE SALT CATALYST; EFFICIENCY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-08-20 | — | — | US | disclosed |
| EP-0040896-B1 | SYNTHESIS OF AMIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-04-25 | — | — | EP | disclosed |
| US-4335787-A | SURFACTANT SYSTEM COMPRISING A HYDROCARBON SULFONATE AND A NITRILE | PHILLIPS PETROLEUM COMPANY (US) | 1982-06-22 | — | — | US | disclosed |
| EP-0046451-A2 | Diaryl-imidazole compounds, methods for their preparation, pharmaceutical drugs containing them and their use | CIBA-GEIGY AG (CH) | 1982-02-24 | — | — | EP | disclosed |
| EP-0040896-A2 | Synthesis of amides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-12-02 | — | — | EP | disclosed |
| EP-0008532-A1 | Synthesis of amines | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-03-05 | — | — | EP | disclosed |
| US-3984336-A | BETA-THIO-PROPIONITRILE, ANTIWEAR AGENTS | MOBIL OIL CORPORATION (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190216726-A1 | Particles, Compositions and Methods for Ophthalmic and/or Other Applications | MUC1, RAB5IF, PDE6C | ALDH1A1 2315/4885MAPK1 4809/4885MAOA 2666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.